MedTrace Logo

Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies

NCT03513835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-02-14

No results posted yet for this study

Summary

The purpose of this study is to develop simple diagnostic screeningtests and investigate potential biomarkers for identifying patients with abnormalities of mitochondrial function, which also can be used as outcome measures in future clinical trials. The study will investigate two submaximal tests: a submaximal handgrip test and a walking test. Furthermore investigators will investigate Acyl-carnitine profiles and GDF-15 levels in patients with mitochondrial myopathy.

Conditions

  • Mitochondrial Myopathies
  • Healthy Controls

Interventions

DIAGNOSTIC_TEST

Diagnostic screenings tests

Handgrip test, 12-minute walk test and 6-minute walk test. Biomarkers: acyl-carnitine profile and GDF-15.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-01
Completion
2019-01-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03513835 on ClinicalTrials.gov